In addition, the binding of celastrol to ROCK2 inhibits the migration of hepatocellular carcinoma, mainly through the impaired ROCK2-mediated phosphorylation of ezrin, resulting in ineffective ezrin activation [285]. The gene discussed is ROCK2; the disease is hepatocellular carcinoma.